Immunotherapy boosts Chemo-Radiation against recurrent nasopharyngeal cancer
NCT ID NCT05340491
First seen May 19, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether adding an immunotherapy drug (anti-PD-1 antibody) to standard chemoradiotherapy helps people with nasopharyngeal cancer that has come back after initial treatment. About 212 adults whose cancer cannot be surgically removed will be randomly assigned to receive either the combination or chemoradiotherapy alone. The main goal is to see if the combination improves overall survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
NOT_YET_RECRUITINGShanghai, China
Contact
-
Fujian Province Cancer Hospital
NOT_YET_RECRUITINGFuzhou, China
Contact
-
Guizhou Cancer Hospital
NOT_YET_RECRUITINGGuiyang, China
Contact
-
Jiangxi Cancer Hospital
RECRUITINGNanchang, China
Contact
-
Peking University Third Hospital
RECRUITINGBeijing, China
Contact
-
Sichuan Cancer Hospital
NOT_YET_RECRUITINGChengdu, China
Contact
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Guangxi Medical University
RECRUITINGNanning, China
Contact
-
The First Affiliated Hospital of Xiamen University
NOT_YET_RECRUITINGXiamen, China
Contact
-
Xijing Hospital
RECRUITINGXi'an, China
Contact
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, China
Contact
-
Zhongnan Hospital of Wuhan University
RECRUITINGWuhan, China
Contact
Conditions
Explore the condition pages connected to this study.